New Delhi: The deadly novel coronavirus in India has crossed another bleak milestone with a record of more than 6 lakhs cases on Friday. India on Friday reported its second highest single-day jump in coronavirus cases in the past 24-hour. As per union health ministry data, India reported 19,148 new cases of coronavirus. The country has also witnessed another spike in new deaths with 434 fatalities in the last 24 hours.
Overall, India’s coronavirus cases tally has now surged to 6,04, 641, out of which 2,26,947 are active cases. More than 3.5 lakh patients have recovered from the disease so far. With this, the recovery rate stood at 59.5 percent which is comparatively higher than many countries.
Of all the cases, Around 90 per cent of total infections in India are from ten states — Maharashtra, Tamil Nadu, Delhi, Gujarat, Uttar Pradesh, West Bengal, Telangana, Andhra Pradesh, Haryana and Karnataka.
In just 5 days, India has witnessed a total of 1 lakh jump in the total number of cases. On Saturday, India was at 5,08,953 and Today, the nationwide caseloads is at 6,04,641.
Of the 19,148, Maharashtra and Tamil Nadu recorded the highest number of cases, comprises 49%. Karnatak and Telangana also saw explosion in the caseloads on Wednesday.
The death toll in India reached 17,834. The states recorded 434 fatalities in last 24 hours. Maharashtra alone recorded 198 fatalities on Wednesday, making it 45% of the total deaths across India.
| STATES/UTs | NEW CASES | NEW DEATHS |
| Maharashtra | 5537 | 198 |
| Tamil Nadu | 3882 | 63 |
| Delhi | 2442 | 61 |
| Karnataka | 1272 | 7 |
| Telangana | 1018 | 7 |
According to medical research body ICMR, over 90.5 lakh samples have been tested so far across India for coronavirus as of July 1. And on Wednesday, over 2.2 lakh samples were tested for covid.
Among the states, Maharashtra has the highest number of cases at 1,80,298, followed by Tamil Nadu at 94,049 and Delhi at 89,802.
Earlier this week, Hyderabad-based Bharat Biotech said the country’s ‘first’ indigenous COVID-19 vaccine COVAXIN, developed by it in collaboration with Indian Council of Medical Research (ICMR) and National Institute of Virology, has got nod for human clinical trials from the Drug Controller General of India.
Globally, More than 10.5 million people have been infected and more than half a million have died since the COVID-19 disease first emerged in China, according to Johns Hopkins University data.